View Older Stories View More Recent Stories

Sep 2, 2025 08:38AM Piper Sandler: 'Alnylam Pharmaceuticals (ALNY) Continues to Impress'
Aug 30, 2025 04:00PM Why public perception matters so much for biotech valuations
Aug 15, 2025 10:58AM Truist Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) Ahead of ESC Data Presentation
Aug 14, 2025 07:57AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Aug 4, 2025 06:11AM Wolfe Research Upgrades Alnylam Pharmaceuticals (ALNY) to Peerperform
Aug 4, 2025 06:09AM Oppenheimer Upgrades Alnylam Pharmaceuticals (ALNY) to Outperform
Aug 1, 2025 10:32AM Alnylam Pharmaceuticals (ALNY) PT Raised to $550 at UBS
Aug 1, 2025 07:45AM Alnylam Pharmaceuticals (ALNY) PT Raised to $450 at Scotiabank
Aug 1, 2025 05:55AM Alnylam Pharmaceuticals (ALNY) PT Raised to $450 at BMO Capital
Jul 31, 2025 08:02AM Alnylam Pharma (ALNY) Tops Q2 EPS by 91c
Jul 30, 2025 08:05AM Alnylam Pharmaceuticals (ALNY) PT Raised to $389 at Bernstein SocGen Group
Jul 29, 2025 04:27PM Raymond James Assumes Alnylam Pharmaceuticals (ALNY) at Outperform
Jul 21, 2025 07:29AM Truist Securities Starts Alnylam Pharmaceuticals (ALNY) at Buy
Jul 17, 2025 08:27AM Alnylam Pharmaceuticals (ALNY) PT Raised to $290 at Cantor Fitzgerald
Jul 16, 2025 07:18AM Alnylam Pharmaceuticals (ALNY) PT Raised to $348 at JPMorgan
Jul 14, 2025 10:04AM Jefferies Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jul 1, 2025 07:29AM Goldman rolls out latest U.S. Conviction List update
Jun 26, 2025 07:15AM Alnylam Pharmaceuticals (ALNY) PT Raised to $377 at Needham
Jun 24, 2025 05:15AM Alnylam Pharmaceuticals (ALNY) PT Raised to $360 at BMO Capital
Jun 18, 2025 10:05AM Alnylam Pharma (ALNY) names Pushkal Garg as Chief Research and Development Officer
Jun 13, 2025 08:58AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'Amvuttra Survey Suggests 2Q Beat'
Jun 11, 2025 07:01AM Instil Bio Inc. (TIL) Appoints John Maraganore to its Board
Jun 9, 2025 06:00AM Alnylam Pharma (ALNY) Receives EU Approval for AMVUTTRA
Jun 3, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
May 30, 2025 09:29AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'HQ Visit Makes Us More Positive About The Q'
May 29, 2025 01:19PM JPMorgan Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
May 14, 2025 09:32AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
May 12, 2025 07:01AM Alnylam Pharma (ALNY) to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study
May 6, 2025 07:13AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
May 1, 2025 08:01AM Alnylam Pharma (ALNY) Tops Q1 EPS by 92c
Apr 28, 2025 08:00AM Alnylam Pharma (ALNY) Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'
Apr 10, 2025 05:32AM Bernstein Recommends Three US Biotech Stocks Amid 'Heightened Regulatory Uncertainty'
Apr 4, 2025 06:46AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Apr 3, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Mar 31, 2025 08:09AM Stifel Raises Price Target on Alnylam Pharmaceuticals (ALNY) to $345
Mar 31, 2025 06:52AM Alnylam Pharmaceuticals (ALNY) PT Raised to $342 at Scotiabank
Mar 31, 2025 05:21AM Alnylam Pharmaceuticals (ALNY) PT Raised to $345 at Stifel
Mar 31, 2025 04:16AM Redburn-Atlantic Starts Alnylam Pharmaceuticals (ALNY) at Buy
Mar 28, 2025 04:45PM Alnylam Pharma (ALNY) Announces FDA Approval of Qfitlia
Mar 27, 2025 09:14AM Bernstein on Alnylam Pharmaceuticals (ALNY): 'A Strident but Unconvincing Bear Case'
Mar 24, 2025 08:58AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'Incrementally More Positive on ALNY and Remain Buyers'
Mar 24, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Mar 24, 2025 02:03AM JPMorgan Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight
Mar 21, 2025 03:30PM Alnylam Pharma (ALNY) call put ratio 1.9 calls to 1 put on 7500 contracts as share price up 10%
Mar 21, 2025 07:44AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Mar 21, 2025 06:56AM Alnylam Pharmaceuticals (ALNY) PT Raised to $338 at Scotiabank
Mar 21, 2025 06:47AM Cantor Fitzgerald Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
Mar 21, 2025 06:46AM Alnylam Pharmaceuticals (ALNY) PT Raised to $390 at Canaccord Genuity
View More Recent Stories View Older Stories